IOVA
Iovance Biotherapeutics Inc
NASDAQ: IOVA · HEALTHCARE · BIOTECHNOLOGY
$3.36
+1.51% today
Updated 2026-04-30
Market cap
$1.41B
P/E ratio
—
P/S ratio
5.36x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$2 – $6
Volume
17.4M
Iovance Biotherapeutics Inc (IOVA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-148.40%
Operating margin
-84.70%
ROE
-55.50%
ROA
-27.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-57140.00 | — | — | — |
| 2009 | — | $-15772.00 | — | — | — |
| 2010 | — | $-1.61M | — | — | — |
| 2011 | $0.00 | $-25.69M | — | — | — |
| 2012 | $0.00 | $-3.31M | — | — | — |
| 2013 | $0.00 | $-25.38M | — | — | — |
| 2014 | $0.00 | $-12.04M | — | — | — |
| 2015 | $0.00 | $-27.66M | — | — | — |
| 2016 | $0.00 | $-52.89M | — | — | — |
| 2017 | $0.00 | $-92.06M | — | — | — |
| 2018 | $0.00 | $-123.58M | — | — | — |
| 2019 | $0.00 | $-187.07M | — | — | — |
| 2020 | $0.00 | $-259.58M | — | — | — |
| 2021 | $0.00 | $-327.82M | — | — | — |
| 2022 | $238000.00 | $-389.92M | -8,880.25% | -167,595.80% | -163,833.19% |
| 2023 | $1.19M | $-444.04M | -804.54% | -38,734.99% | -37,345.42% |
| 2024 | $164.07M | $-372.18M | 24.43% | -240.92% | -226.84% |
| 2025 | $263.50M | $-390.98M | 97.23% | -153.08% | -148.38% |